{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:39:33Z","timestamp":1785929973590,"version":"3.56.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      species are one of the most common causes of ICU-onset bloodstream infection (BSI). Yet, there is no robust guidance on when to initiate empiric antifungals for ICU patients suspected of BSI. We compared patients with ICU-onset candidemia vs. ICU-onset bacteremia to determine which patients may benefit from empiric antifungals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>We compared characteristics between patients with bacteremia vs. candidemia at time of culture. We determined risk factors for death and constructed a multivariable regression to determine if candidemia is an independent risk factor for death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting\/Patients:<\/jats:title>\n                    <jats:p>\n                      We included ICU patients from a hospital system in Houston, Texas (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 8 hospitals) with a BSI from 2016 to 2023 and validated our findings using ICU patients with a BSI in the publicly available Medical Information Mart for Intensive Care (MIMIC)-IV cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      Of 1509 total patients in our primary cohort, 290 (19.2%) had candidemia and 1219 (80.8%) had bacteremia. Patients with candidemia were more likely to be on invasive mechanical ventilation (72.8% vs. 52.8%;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), vasopressors (39.3% vs. 24.0%;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), and continuous renal replacement therapy (15.2% vs. 9.4%;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.006) at the time of culture. They contracted infection later in ICU stay than bacteremia patients (7.2 vs. 5.0 d;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) and were more likely to die within 30 days of culture (unadjusted odds ratio [OR], 1.62; 95% CI, 1.25\u20132.09). After adjusting for ICU interventions (invasive mechanical ventilation, vasopressors, and continuous renal replacement therapy) and baseline parameters, candidemia was not independently associated with mortality compared with bacteremia in our primary cohort (OR, 1.21; 95% CI, 0.92\u20131.60) but was in the MIMIC-IV cohort (OR, 1.48; 95% CI, 1.003\u20132.17).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Patients with significant ICU resource utilization are at increased risk for candidemia. Our data suggest that when initiating empiric antibiotics in patients requiring high-resource ICU care, empiric antifungal therapy should be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006963","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:00:38Z","timestamp":1770130838000},"page":"246-256","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Utilization of Intensive Care Interventions in Critically Ill Patients With Candidemia Versus Bacteremia: A Multicenter Retrospective Cohort Study"],"prefix":"10.1097","volume":"54","author":[{"given":"Mary North","family":"Jones","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, TX."},{"name":"Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nigo","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, TX."},{"name":"Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX."},{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Casarin","sequence":"additional","affiliation":[{"name":"Center for Precision Surgery, Houston Methodist Research Institute, Houston, TX."},{"name":"LaSIE, UMR 7356, CNRS, La Rochelle Universit\u00e9, La Rochelle, France."},{"name":"Department of Surgery, Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kurian","sequence":"additional","affiliation":[{"name":"Department of Medicine, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarjav","family":"Sanghvi","sequence":"additional","affiliation":[{"name":"Center for Health Data Science and Analytics, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enshuo","family":"Hsu","sequence":"additional","affiliation":[{"name":"Center for Health Data Science and Analytics, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Jones","sequence":"additional","affiliation":[{"name":"Center for Health Data Science and Analytics, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashton","family":"Connor","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medical College, New York, NY."},{"name":"Department of Surgery, Weill Cornell Medical College, New York, NY."},{"name":"J.C. Walter, Jr. Transplant Center, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Corry","sequence":"additional","affiliation":[{"name":"Department of Medicine, Baylor College of Medicine, Houston, TX."},{"name":"Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX."},{"name":"Biology of Inflammation Center, Baylor College of Medicine, Houston, TX."},{"name":"Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Department of Veterans Affairs Medical Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar A.","family":"Arias","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, TX."},{"name":"Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX."},{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max W.","family":"Adelman","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, TX."},{"name":"Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX."},{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY."},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"R2-20260203","doi-asserted-by":"crossref","first-page":"106229","DOI":"10.1016\/j.jinf.2024.106229","article-title":"Attributable mortality of Candidemia\u2014results from the ECMM Candida III multinational European observational cohort study.","volume":"89","author":"Salmanton-Garc\u00eda","year":"2024","journal-title":"J Infect"},{"key":"R3-20260203","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1093\/cid\/ciaa193","article-title":"Burden of Candidemia in the United States, 2017.","volume":"71","author":"Tsay","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R4-20260203","doi-asserted-by":"crossref","first-page":"ofac097","DOI":"10.1093\/ofid\/ofac097","article-title":"Economic burden of fungal diseases in the United States.","volume":"9","author":"Benedict","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R5-20260203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vhri.2019.07.002","article-title":"The economic burden of candidemia and invasive candidiasis: A systematic review.","volume":"21","author":"Wan Ismail","year":"2020","journal-title":"Value Health Reg Issues"},{"key":"R6-20260203","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/CCM.0000000000005662","article-title":"Epidemiology of ICU-onset bloodstream infection: Prevalence, pathogens, and risk factors among 150,948 ICU patients at 85 U.S. hospitals.","volume":"50","author":"Gouel-Cheron","year":"2022","journal-title":"Crit Care Med"},{"key":"R7-20260203","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13613-020-00755-8","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: A single-center retrospective 10-year analysis.","volume":"10","author":"Schroeder","year":"2020","journal-title":"Ann Intensive Care"},{"key":"R8-20260203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: Results of the EUCANDICU project.","volume":"23","author":"Bassetti","year":"2019","journal-title":"Crit Care"},{"key":"R9-20260203","doi-asserted-by":"crossref","first-page":"e0252165","DOI":"10.1371\/journal.pone.0252165","article-title":"Candidemia in intensive care units over nine years at a large Italian university hospital: Comparison with other wards.","volume":"16","author":"Mazzanti","year":"2021","journal-title":"PLoS One"},{"key":"R10-20260203","first-page":"597","article-title":"Dynamics and predictors of mortality due to candidemia caused by different Candida species: Comparison of intensive care unit-associated candidemia (ICUAC) and non-ICUAC.","volume":"7","author":"Kwon","year":"2021","journal-title":"J Fungi (Basel, Switzerland)"},{"key":"R11-20260203","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021.","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"R12-20260203","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/QCO.0000000000000684","article-title":"Mind the gaps: Challenges in the clinical management of invasive candidiasis in critically ill patients.","volume":"33","author":"Pe\u00e7anha-Pietrobom","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"R13-20260203","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: The EMPIRICUS randomized clinical trial.","volume":"316","author":"Timsit","year":"2016","journal-title":"JAMA"},{"key":"R14-20260203","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/mmy\/myab043","article-title":"Clinical predictive models of invasive Candida infection: A systematic literature review.","volume":"59","author":"Rauseo","year":"2021","journal-title":"Med Mycol"},{"key":"R15-20260203","doi-asserted-by":"crossref","first-page":"R198","DOI":"10.1186\/cc10366","article-title":"Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: A matched case-control study.","volume":"15","author":"Hermsen","year":"2011","journal-title":"Crit Care"},{"key":"R16-20260203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting.","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R17-20260203","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.","volume":"34","author":"Le\u00f3n","year":"2006","journal-title":"Crit Care Med"},{"key":"R18-20260203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13054-020-2766-1","article-title":"Risk factors for candidemia: A prospective matched case-control study.","volume":"24","author":"Poissy","year":"2020","journal-title":"Crit Care"},{"key":"R19-20260203","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.1989.00390100145030","article-title":"Risk factors for hospital-acquired candidemia. A matched case-control study.","volume":"149","author":"Wey","year":"1989","journal-title":"Arch Intern Med"},{"key":"R20-20260203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/myc.13211","article-title":"Risk factors for candidaemia: A prospective multi-centre case-control study.","volume":"64","author":"Keighley","year":"2021","journal-title":"Mycoses"},{"key":"R21-20260203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.medin.2015.08.001","article-title":"Risk factors for candidemia in non-neutropenic critical patients in Colombia.","volume":"40","author":"Ort\u00edz Ruiz","year":"2016","journal-title":"Med Intensiva"},{"key":"R22-20260203","first-page":"313","article-title":"Risk factors for candidaemia and their cumulative effect over time in a cohort of critically ill, non-neutropenic patients.","volume":"20","author":"Aljeboori","year":"2018","journal-title":"Crit Care Resusc"},{"key":"R23-20260203","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/mmy\/myy127","article-title":"Risk factors for noncatheter-related Candida bloodstream infections in intensive care units: A multicenter case-control study.","volume":"57","author":"Arslan","year":"2019","journal-title":"Med Mycol"},{"key":"R24-20260203","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s15010-017-1050-z","article-title":"Risk factors and predictors of mortality of Candidaemia among critically ill patients: Role of antifungal prophylaxis in its development and in selection of non-albicans species.","volume":"45","author":"Papadimitriou-Olivgeris","year":"2017","journal-title":"Infection"},{"key":"R25-20260203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejim.2017.03.005","article-title":"Assessment of risk factors for Candidemia in non-neutropenic patients hospitalized in internal medicine wards: A multicenter study.","volume":"41","author":"Falcone","year":"2017","journal-title":"Eur J Intern Med"},{"key":"R26-20260203","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/myc.13177","article-title":"Attributable mortality of candidemia after introduction of echinocandins.","volume":"63","author":"Cornely","year":"2020","journal-title":"Mycoses"},{"key":"R27-20260203","doi-asserted-by":"crossref","first-page":"e15038","DOI":"10.1111\/ctr.15038","article-title":"Candidemia in thoracic solid organ transplant recipients: Characteristics and outcomes relative to matched uninfected and bacteremic thoracic organ transplant recipients.","volume":"37","author":"Eichenberger","year":"2023","journal-title":"Clin Transplant"},{"key":"R28-20260203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.diagmicrobio.2019.04.007","article-title":"Predicting candidemia in the internal medicine wards: A comparison with gram-negative bacteremia-a retrospectives study.","volume":"95","author":"Atamna","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R29-20260203","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/pathogens10101349","article-title":"Serum cytokine profile in patients with candidemia versus bacteremia.","volume":"10","author":"Taj-Aldeen","year":"2021","journal-title":"Pathogens"},{"key":"R30-20260203","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13054-017-1763-5","article-title":"Combined use of serum (1,3)-\u03b2-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.","volume":"21","author":"Giacobbe","year":"2017","journal-title":"Crit Care"},{"key":"R31-20260203","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study.","volume":"39","author":"Kett","year":"2011","journal-title":"Crit Care Med"},{"key":"R32-20260203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13054-016-1229-1","article-title":"Characteristics and risk factors for 28-day mortality of hospital-acquired fungemias in ICUs: Data from the EUROBACT study.","volume":"20","author":"Paiva","year":"2016","journal-title":"Crit Care"},{"key":"R33-20260203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41597-023-02136-9","article-title":"MIMIC-IV, a freely accessible electronic health record dataset.","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"R35-20260203","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1469-0691.2010.03422.x","article-title":"Decreasing Candidaemia rate in abdominal surgery patients after introduction of fluconazole prophylaxis*.","volume":"17","author":"Holzknecht","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R36-20260203","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/2110-5820-1-50","article-title":"Evaluation of \u201cCandida score\u201d in critically ill patients: A prospective, multicenter, observational, cohort study.","volume":"1","author":"Leroy","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R37-20260203","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1086\/502581","article-title":"Excess mortality, hospital stay, and cost due to Candidemia: A case-control study using data from population-based Candidemia surveillance.","volume":"26","author":"Morgan","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R38-20260203","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00003246-199806000-00019","article-title":"Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units.","volume":"26","author":"Lundberg","year":"1998","journal-title":"Crit Care Med"},{"key":"R39-20260203","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamainternmed.2023.2067","article-title":"Detecting selection bias in observational studies\u2014when interventions work too fast.","volume":"183","author":"Mohyuddin","year":"2023","journal-title":"JAMA Intern Med"},{"key":"R40-20260203","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/myc.13376","article-title":"Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital.","volume":"64","author":"Battistolo","year":"2021","journal-title":"Mycoses"},{"key":"R41-20260203","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: How nonculture diagnostics will improve understanding of disease spectrum and transform patient care.","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R42-20260203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk factors for invasive candida infection in critically ill patients: A systematic review and meta-analysis.","volume":"161","author":"Thomas-R\u00fcddel","year":"2022","journal-title":"Chest"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:00:44Z","timestamp":1770130844000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006963","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]}}}